WASATCH ADVISORS LP 13D and 13G filings for Intra-Cellular Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 12:40 pm Sale | 2024-02-09 | 13G | Intra-Cellular Therapies, Inc. ITCI | WASATCH ADVISORS LP | 3,627,308 3.800% | -1,112,837 (-23.48%) | Filing |
| 2023-01-10 2:38 pm Sale | 2023-01-10 | 13G | Intra-Cellular Therapies, Inc. ITCI | WASATCH ADVISORS LP | 4,740,145 5.010% | -3,495,623 (-42.44%) | Filing |
| 2022-02-10 1:38 pm Sale | 2022-02-10 | 13G | Intra-Cellular Therapies, Inc. ITCI | WASATCH ADVISORS LP | 8,235,768 10.100% | -83,444 (-1.00%) | Filing |
| 2021-12-02 11:31 am Purchase | 2021-12-02 | 13G | Intra-Cellular Therapies, Inc. ITCI | WASATCH ADVISORS LP | 8,319,212 10.200% | 1,985,312 (+31.34%) | Filing |